LSE · HEMO.L
Hemogenyx Pharmaceuticals Plc
£6.34-£0.46 (-6.73%)
Hemogenyx Pharmaceuticals Plc’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
Loading market information…
OTC · PVTTF · USD
Stock price, earnings
Quote as of Dec 30, 2022, 08:50 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Pivotal Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Pivotal Therapeutics Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Pivotal Therapeutics Inc. is a specialized pharmaceutical firm primarily dedicated to addressing cardiovascular ailments and promoting general well-being. The company's flagship offering, VASCAZEN, is a medical food available by prescription only. It's specifically designed for the clinical dietary intervention of cardiovascular disease in individuals diagnosed with coronary heart disease who also exhibit low levels of Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in their bloodstream. Furthermore, Pivotal Therapeutics markets OMAZEN, which aims to support general health by boosting Omega-3 fatty acid concentrations. Its Benefishial product line is under development, targeting a wide range of health needs such as comprehensive well-being, heart health, maternal and fetal health, and specific formulations for toddlers, children, and even pets. A significant pipeline asset, PVT-100, is being developed to stabilize fragile plaque formations in patients undergoing carotid endarterectomy. Currently, VASCAZEN is distributed within the United States, while OMAZEN is sold in Canada. The corporate headquarters for Pivotal Therapeutics Inc. are situated in Woodbridge, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
£6.34-£0.46 (-6.73%)
Hemogenyx Pharmaceuticals Plc’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
$0.00$0.00 (0.0%)
CuraScientific Corp: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00+$0.00 (+900.0%)
Vitalibis, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.08-$0.00 (-2.33%)
Kiromic BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.56% below the high.
$0.01$0.00 (0.0%)
Aladdin Healthcare Technologies SE: Healthcare · Medical - Healthcare Information Services.
$0.00+$0.00 (0.0%)
Advanced Proteome Therapeutics Corporation: Healthcare · Biotechnology.
$0.00+$0.00 (+9,900.0%)
MedMen Enterprises Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00+$0.00 (+29,900.0%)
Miravant Medical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
